FDA Allows Vytorin Labeling for Use in Kidney Disease - MedPage Today PDF Print
MedPage Today
The FDA's Endocrinologic and Metabolic Drugs Advisory Committee also voted 10-6 against recommending approval for use of the drug in end-stage renal disease (ESRD) patients on dialysis. The new labeling announced by the FDA follows that recommendation

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.